Scholar Rock Holding (SRRK) Interest & Investment Income (2024 - 2026)
Scholar Rock Holding (SRRK) posted quarterly Interest & Investment Income of $2.9 million for Q1 2026, down 30.6% year-over-year from $4.2 million in Q1 2025, and down 16.76% quarter-over-quarter from $3.5 million in Q4 2025.
Scholar Rock Holding (SRRK) Interest & Investment Income (2024 - 2026) Analysis & Trends
Scholar Rock Holding's Interest & Investment Income history runs 3 years deep, the most recent figure standing at $2.9 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 30.6% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $12.6 million (down 7.26% YoY), while the FY2025 annual figure was $13.9 million, up 9.6% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $2.9 million, down from $3.5 million in the prior quarter.
- The five-year high for Interest & Investment Income was $4.6 million in Q4 2024, with the low at $2.1 million in Q3 2024.
- The 3-year median for Interest & Investment Income is $3.3 million (2024), against an average of $3.3 million.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income jumped 31.2% in 2025, then slumped 30.6% in 2026.
- Scholar Rock Holding's Interest & Investment Income stood at $4.6 million in 2024, then retreated by 22.69% to $3.5 million in 2025, then fell by 16.76% to $2.9 million in 2026.
- Business Quant data shows SRRK's Interest & Investment Income at $2.9 million in Q1 2026, $3.5 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Scholar Rock Holding | 6.39 Bn | 6.39 Bn | - | 4.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.09 Mn |
| Mar 31, 2026 | 2.94 Mn |
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 3.41 Mn |
| Mar 31, 2025 | 4.23 Mn |
| Dec 31, 2024 | 4.56 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.72 Mn |
| Mar 31, 2024 | 3.32 Mn |